US 11660295
Glucocorticoid receptor modulators to treat cervical cancer
granted A61KA61K31/337A61K31/4745
Quick answer
US patent 11660295 (Glucocorticoid receptor modulators to treat cervical cancer) held by Corcept Therapeutics Incorporated expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/337, A61K31/4745, A61P, A61P35/00